Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors.
Saved in:
| Title: | Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors. |
|---|---|
| Authors: | Savelieva M; Novartis Pharma AG, CH-4002, Basel, Switzerland., Woo MM; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Schran H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Mu S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Nedelman J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Capdeville R; Novartis Pharma AG, CH-4002, Basel, Switzerland. renaud.capdeville@novartis.com. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2015 Jun; Vol. 71 (6), pp. 663-672. Date of Electronic Publication: 2015 May 05. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
